IA Ventures — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Aclidaclid.bioOct 2023 · $3.3M
Aclid provides an automation platform for biosecurity and biosafety compliance, offering real-time screening that generates threat assessments and risk profiles for genes, libraries, pools, viral vectors, and plasmids.
BiotechCybersecurityDeep TechSaaSNew York, US
Kevin Flyangolts(Executive Officer, Director, Promoter)in
BoardAlex Iskold(Director)in
Co-investors2048 VenturesCoalition Operators
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.